Skip to content
PaperFren

Concept

Depression Treatment

Depression treatment evidence covers pharmacological, psychological, and digital interventions aimed at reducing depressive symptoms.

Mental-health care is outcome-driven; symptom scales and trial arms show what moves scores.

Studies

8

Findings

6

8 supporting · 0 challenging · 0 qualifying citations

Open tensions

1

Currently

What we know

  1. Multiple studies in this library examine depression treatment with empirical patient or population outcomes rather than opinion alone.
  2. Immediate treatment improved ~5.4 BDI points (d=0.58) with a significant condition×time interaction; delayed group showed essentially no BDI change over the same interval.
  3. Low-to-moderate intake (>5–15 g/day) had HR 0.72 (95% CI 0.53–0.98); wine dominated alcohol intake (82% of variability); heavy drinkers appeared at higher risk.
  4. CDI rates were 282.9 vs 197.1 per 100,000 person-years with vs without depression; adjusted odds of CDI were 36% higher with major depression; widowhood and living alone also associated.
  5. iCBT produced moderate between-group benefits on PHQ-9 (Hedges g=0.78) and GAD-7 (g=0.72), plus large effects on diabetes distress and general distress. About 66% completed all six lessons; 51% of iCBT completers with data showed reliable PHQ-9 improvement vs 18% of TAU.

Largest unresolved question

Effect sizes and settings differ across depression treatment studies — digital vs clinic, trial vs observational — so results should not be pooled casually.

Common misconceptions

  • Depression Treatment findings always generalise to every clinic.

    These studies are context-bound; designs, populations, and endpoints limit transfer.

Related